Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Fish and Richardson
AstraZeneca
Mallinckrodt
Chinese Patent Office
McKinsey
Daiichi Sankyo
Colorcon
Cantor Fitzgerald

Generated: August 20, 2018

DrugPatentWatch Database Preview

Pentoxifylline - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for pentoxifylline and what is the scope of pentoxifylline patent protection?

Pentoxifylline is the generic ingredient in three branded drugs marketed by Actavis Elizabeth, Apotex, Heritage Pharms Inc, Impax Labs, Mylan, Pliva, Teva, Valeant Pharms, Watson Labs, Upsher-smith Labs, and Us Pharm Holdings, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for pentoxifylline. Fifteen suppliers are listed for this compound.

Pharmacology for pentoxifylline
Synonyms for pentoxifylline
1-(5-Oxohexyl)-3,7-dimethylxanthine
1-(5-Oxohexyl)theobromine
1-(5-oxohexyl)theobromine (pentoxifylline)
1,2,3,6-Tetrahydro-3,7-dimethyl-1-(5-oxohexyl)-2,6-purindion
1H-Purine-2,6-dione, 3,7-dihydro-3,7-dimethyl-1-(5-oxohexyl)-
2a3c
3,7-Dihydro-3,7-dimethyl-1-(5-oxohexyl)-1H-purine-2,6-dione
3,7-Dimethyl-1-(5-oxo-hexyl)-3,7-dihydro-purine-2,6-dione
3,7-Dimethyl-1-(5-oxohexyl) xantine
3,7-dimethyl-1-(5-oxohexyl)-1,3,7-trihydropurine-2,6-dione
3,7-dimethyl-1-(5-oxohexyl)-1H-purine-2,6-dione
3,7-dimethyl-1-(5-oxohexyl)-1H-purine-2,6(3H,7H)-dione
3,7-Dimethyl-1-(5-oxohexyl)-1H,3H-purin-2,6-dione
3,7-dimethyl-1-(5-oxohexyl)-2,3,6,7-tetrahydro-1H-purine-2,6-dione
3,7-Dimethyl-1-(5-oxohexyl)-3,7-dihydro-1H-purine-2,6-dione
3,7-Dimethyl-1-(5-oxohexyl)-3,7-dihydro-1H-purine-2,6-dione #
3,7-dimethyl-1-(5-oxohexyl)-3,7-dihydropurine-2,6-dione
3,7-dimethyl-1-(5-oxohexyl)-xanthine
3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dione
3,7-Dimethyl-1-(5-oxohexyl)xanthine
3,7-Dimethyl-1-(5-oxohexyl)xantine
3arr
3aru
3tvx
5-26-14-00081 (Beilstein Handbook Reference)
6493-05-6
AB00052363
AB00052363_18
AB00052363_21
AB00052363-17
AC-8381
AC1L1IUN
Agapurin
Agapurin Retard
AKOS000541484
AN-8052
API0003788
Artal (TN)
AS-13662
Azupentat
BAS 00897429
BB_SC-2111
BBL016497
BDBM10850
BG0286
BIDD:GT0174
BL 191
BL-191
BL191
BPBio1_000167
BRD-K57569181-001-05-1
BRN 0558929
BSPBio_000151
BSPBio_003439
BYPFEZZEUUWMEJ-UHFFFAOYSA-N
C07424
C13H18N4O3
CAS-1677687
CAS-6493-05-6
CCG-36382
CCRIS 6832
CHEBI:7986
CHEMBL628
cis-9-Octadecenoyl coenzyme A
CPD000035998
CS-2954
CTK8G2308
D00501
D09QEI
DB00806
Dimethyloxohexylxanthine
DivK1c_000729
DR000943
DSSTox_CID_3437
DSSTox_GSID_23437
DSSTox_RID_77028
DTXSID7023437
Durapental
EHT 0201
EHT 0202
EHT-0201
EHT-201
EHT0201
EINECS 229-374-5
EU-0100936
Flexital (TN)
FT-0603570
FT-0657886
GTPL7095
H3041
Hemovas
HMS1568H13
HMS1922E16
HMS2051N06
HMS2090H13
HMS2093G21
HMS2095H13
HMS2235C16
HMS3262L14
HMS3370D09
HMS3393N06
HMS502E11
HY-B0715
I06-1592
IDI1_000729
Ikomio
IN1161
J10071
KBio1_000729
KBio2_001924
KBio2_004492
KBio2_007060
KBio3_002942
KBioGR_000893
KBioSS_001924
Lopac-P-1784
Lopac0_000936
LP00936
LP069653
LS-149385
MCULE-9951939936
MFCD00063379
MLS000079026
MLS000758298
MLS001201764
MLS001424051
MolPort-001-823-263
NC00255
NCGC00015801-01
NCGC00015801-02
NCGC00015801-03
NCGC00015801-04
NCGC00015801-05
NCGC00015801-06
NCGC00015801-07
NCGC00015801-08
NCGC00015801-09
NCGC00015801-10
NCGC00015801-12
NCGC00067069-02
NCGC00067069-03
NCGC00067069-04
NCGC00067069-05
NCGC00178062-01
NCGC00178062-02
NCGC00261621-01
NINDS_000729
NSC 637086
NSC-637086
NSC-758481
NSC637086
NSC758481
Opera_ID_1800
Oxpentifylline
P 1784
P2050
PDSP1_001015
PDSP2_000999
Pentopak
Pentox (TN)
Pentoxifilina
Pentoxifilina [INN-Spanish]
Pentoxifyllin
Pentoxifylline (JAN/USP/INN)
Pentoxifylline [USAN:INN:JAN]
Pentoxifylline [USAN:USP:INN:BAN:JAN]
Pentoxifyllinum
Pentoxifyllinum [INN-Latin]
Pentoxil
Pentoxil (TN)
Pentoxin (TN)
Pentoxiphyllin
Pentoxiphylline
Pentoxiphyllium
Pentoxyfilline
Pentoxyfylline
PENTOXYPHYLINE
Pentoxyphyllin
Pentoxyphylline
Pharmakon1600-01503611
PNX
Prestwick_608
Prestwick0_000196
Prestwick1_000196
Prestwick2_000196
Prestwick3_000196
Px
Ralofect
Rentylin
SAM001247011
SBI-0050910.P003
SC-23298
SCHEMBL34039
SD6QCT3TSU
SMR000035998
SPBio_001221
SPBio_002072
Spectrum_001444
SPECTRUM1503611
Spectrum2_001181
Spectrum3_001820
Spectrum4_000227
Spectrum5_001161
SR-01000075641-4
ST50242554
STK177321
Theobromine, 1-(5-oxohexyl)-
Torental
Tox21_110223
Tox21_110223_1
Tox21_500936
Trental
Trental (TN)
UNII-SD6QCT3TSU
V0152
Vasofirin
Vazofirin
VZ33607
ZINC1530776

US Patents and Regulatory Information for pentoxifylline

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Upsher-smith Labs PENTOXIL pentoxifylline TABLET, EXTENDED RELEASE;ORAL 074962-001 Mar 31, 1999 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Valeant Pharms PENTOXIFYLLINE pentoxifylline TABLET, EXTENDED RELEASE;ORAL 075028-001 Jul 20, 1998 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Us Pharm Holdings TRENTAL pentoxifylline TABLET, EXTENDED RELEASE;ORAL 018631-001 Aug 30, 1984 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apotex PENTOXIFYLLINE pentoxifylline TABLET, EXTENDED RELEASE;ORAL 075191-001 Jun 9, 1999 AB RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs PENTOXIFYLLINE pentoxifylline TABLET, EXTENDED RELEASE;ORAL 075107-001 Sep 4, 1998 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Impax Labs PENTOXIFYLLINE pentoxifylline TABLET, EXTENDED RELEASE;ORAL 075093-001 Aug 10, 1999 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan PENTOXIFYLLINE pentoxifylline TABLET, EXTENDED RELEASE;ORAL 074425-001 Jul 8, 1997 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for pentoxifylline

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Pharm Holdings TRENTAL pentoxifylline TABLET, EXTENDED RELEASE;ORAL 018631-001 Aug 30, 1984 ➤ Sign Up ➤ Sign Up
Us Pharm Holdings TRENTAL pentoxifylline TABLET, EXTENDED RELEASE;ORAL 018631-001 Aug 30, 1984 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Healthtrust
Boehringer Ingelheim
Covington
Accenture
UBS
AstraZeneca
Mallinckrodt
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.